Paper Details

  1. Home
  2. Paper Details

Antiviral Therapy in Patients with Hepatitis C Virus-Induced Cirrhosis.

Author: BaillyFrançois, PradatPierre, VirlogeuxVictor, ZoulimFabien

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This study reviewed the evolution of hepatitis C virus (HCV) treatment options, highlighting the development of direct-acting antivirals (DAAs) and their improved efficacy and safety profiles compared to interferon-based therapies. DAAs have achieved sustained virological response rates of up to 95% in both naïve and previously treated patients.
Paper Details　
Original Abstract of the Article :
Opportunities to treat infection with hepatitis C virus (HCV) are evolving rapidly. From the introduction of interferon (IFN)-α monotherapy in the early 1990s to the approval of telaprevir- and boceprevir-based triple therapies with pegylated (PEG)-IFN-α and ribavirin (RBV) in 2011, the chances of c...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1159/000375359

データ提供：米国国立医学図書館（NLM）

Antiviral Therapy: Navigating the Desert of Hepatitis C Virus Infection

Hepatitis C virus (HCV) infection, a persistent and potentially life-threatening condition, presents a challenging landscape for clinicians. This review explores the evolution of antiviral therapy for HCV infection, highlighting the dramatic advancements made in recent years. The authors, like seasoned desert explorers, navigate the ever-changing terrain of HCV treatment, seeking to identify the most effective and safe approaches.

A Promising Oasis: Antiviral Therapies Offer Hope

The review highlights the significant progress made in developing effective antiviral therapies for HCV infection. The authors emphasize the dramatic improvements in cure rates achieved with the introduction of new direct-acting antivirals (DAAs). This is like discovering a hidden oasis in a vast and unforgiving desert, offering a much-needed respite from the debilitating effects of HCV infection.

Navigating the Treatment Landscape: Choosing the Right Path

The review underscores the importance of carefully selecting the most appropriate antiviral regimen based on individual patient factors, including the genotype of the HCV infection and the presence of liver cirrhosis. This is akin to navigating a complex and challenging desert terrain, requiring a deep understanding of the landscape and the risks involved.

Dr. Camel's Conclusion

This review provides a valuable roadmap for navigating the treatment landscape of HCV infection. It highlights the remarkable advancements in antiviral therapy, offering a beacon of hope for patients facing this challenging condition. The authors emphasize the importance of personalized medicine, tailoring treatment strategies to individual needs and ensuring optimal outcomes. This review reminds us that, like a desert explorer, we must continually seek new oases of hope in the battle against HCV infection.

Date :
  1. Date Completed 2016-04-04
  2. Date Revised 2022-03-16
Further Info :

Pubmed ID

26159282

DOI: Digital Object Identifier

10.1159/000375359

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.